James Lightman Sold 3105 shares of Wright Medical Group N.V. (WMGI) in an Insider Trade; Profile of 1 Analysts Covering Cameco (CCJ)

June 7, 2018 - By Ellis Scott

Wright Medical Group N.V. (NASDAQ:WMGI) Logo

Among 6 analysts covering Cameco (NYSE:CCJ), 1 have Buy rating, 2 Sell and 3 Hold. Therefore 17% are positive. Cameco had 14 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Buy” on Friday, October 20. As per Tuesday, November 3, the company rating was maintained by RBC Capital Markets. The rating was downgraded by Scotia Capital on Thursday, April 7 to “Sector Perform”. RBC Capital Markets downgraded the shares of CCJ in report on Thursday, February 2 to “Sector Perform” rating. Credit Suisse maintained the stock with “Neutral” rating in Wednesday, April 19 report. On Tuesday, July 18 the stock rating was downgraded by Credit Suisse to “Underperform”. Bank of America maintained Cameco Corporation (NYSE:CCJ) on Wednesday, October 4 with “Underperform” rating. Bank of America upgraded Cameco Corporation (NYSE:CCJ) on Thursday, January 12 to “Neutral” rating. The stock of Cameco Corporation (NYSE:CCJ) has “Sector Perform” rating given on Tuesday, May 22 by RBC Capital Markets. As per Tuesday, February 14, the company rating was upgraded by BMO Capital Markets. See Cameco Corporation (NYSE:CCJ) latest ratings:

22/05/2018 Broker: RBC Capital Markets Old Rating: Outperform New Rating: Sector Perform Downgrade

Analysts await Wright Medical Group N.V. (NASDAQ:WMGI) to report earnings on August, 1. They expect $-0.07 EPS, 0.00% or $0.00 from last year’s $-0.07 per share. After $-0.01 actual EPS reported by Wright Medical Group N.V. for the previous quarter, Wall Street now forecasts 600.00% negative EPS growth.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.64 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

Wright Medical Group N.V. SVP – General Counsel & Sec and an insider James Lightman in the last few days made a sale of 3,105 company shares having a value of $76,445 at an avg market stock price per share of $24.6. The regulatory filing shows that James Lightman now holds precisely 0.04% of the Netherlands-based company’s market capitalization This sale was performed on June 6, 2018. A legal document filed with the SEC and on hand for review here, shows more details of the sale.

The stock decreased 0.20% or $0.05 during the last trading session, reaching $24.93. About 519,907 shares traded. Wright Medical Group N.V. (NASDAQ:WMGI) has declined 9.52% since June 7, 2017 and is downtrending. It has underperformed by 22.09% the S&P500.

Among 19 analysts covering Wright Medical Group (NASDAQ:WMGI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. Wright Medical Group has $3400 highest and $22 lowest target. $27.42’s average target is 9.99% above currents $24.93 stock price. Wright Medical Group had 46 analyst reports since August 20, 2015 according to SRatingsIntel. JP Morgan upgraded the shares of WMGI in report on Wednesday, July 13 to “Overweight” rating. The stock has “Neutral” rating by Bank of America on Tuesday, April 11. On Wednesday, January 17 the stock rating was maintained by RBC Capital Markets with “Buy”. Oppenheimer maintained it with “Perform” rating and $24 target in Monday, November 30 report. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Buy” rating given on Monday, March 12 by Cantor Fitzgerald. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) earned “Buy” rating by Piper Jaffray on Tuesday, January 2. The company was maintained on Monday, October 2 by RBC Capital Markets. On Monday, January 8 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Buy” rating given on Monday, February 22 by Needham. Piper Jaffray maintained the shares of WMGI in report on Wednesday, September 2 with “Hold” rating.

More notable recent Wright Medical Group N.V. (NASDAQ:WMGI) news were published by: Globenewswire.com which released: “Wright Medical Group NV Reports 2018 First Quarter Financial Results” on May 09, 2018, also Nasdaq.com with their article: “CORRECT AND REPLACE: Wright Medical Group NV to Present at Jefferies Global Healthcare Conference” published on May 21, 2018, Nasdaq.com published: “Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group NV ..” on May 21, 2018. More interesting news about Wright Medical Group N.V. (NASDAQ:WMGI) were released by: Nasdaq.com and their article: “Wright Medical Group NV to Present at Jefferies Global Healthcare Conference” published on May 17, 2018 as well as Benzinga.com‘s news article titled: “40 Stocks Moving In Thursday’s Mid-Day Session” with publication date: May 10, 2018.

The stock increased 6.79% or $0.77 during the last trading session, reaching $12.11. About 5.94 million shares traded or 167.66% up from the average. Cameco Corporation (NYSE:CCJ) has risen 12.74% since June 7, 2017 and is uptrending. It has outperformed by 0.17% the S&P500. Some Historical CCJ News: ; 27/04/2018 – CAMECO CORP QTRLY REVENUE $439 MLN VS $393 MLN; 27/04/2018 – Cameco Expects Cash Flow in 2018 to Be Similar to 2017; 27/04/2018 – CAMECO ANNUAL GUIDANCE LARGELY UNCHANGED; 25/04/2018 – Cameco Forms Golden Cross: Technicals; 27/04/2018 – Cameco 1Q Adj EPS C$0.06; 27/04/2018 – Cameco 1Q Net C$55M; 26/03/2018 – ISOENERGY – ENTERED INTO AN AGREEMENT WITH CAMECO CORP., ORANO CANADA INC. AND JCU EXPLORATION COMPANY TO ACQUIRE 100% INTEREST IN 33 MINERAL CLAIMS; 27/04/2018 – Cameco turns to profit on lower costs, higher uranium prices; 27/04/2018 – Cameco 1Q EPS C$0.14; 27/04/2018 – CAMECO 1Q ADJ EPS C$0.06, EST. LOSS/SHR C$0.01

Cameco Corporation produces and sells uranium worldwide. The company has market cap of $4.83 billion. It operates through three divisions: Uranium, Fuel Services, and NUKEM. It currently has negative earnings. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrates.

Another recent and important Cameco Corporation (NYSE:CCJ) news was published by Seekingalpha.com which published an article titled: “Uranium sector should see further price rise, analyst says” on June 06, 2018.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>